Subconjunctival injection of low doses of mitomycin C: effects on fibroblast proliferation

I Pinilla1, J M Larrosa, V Polo

  • 1Department of Ophthalmology, Miguel Servet Hospital, Zaragoza, Spain. sope.pini@sendanet.es

Insights

Low doses of mitomycin C (MMC) via subconjunctival injection significantly inhibit fibroblast populations in rabbit conjunctiva and sclera. This finding is crucial for understanding MMC

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • Mitomycin C (MMC) is used in ophthalmic surgery.
  • Its effect on fibroblast viability after subconjunctival injection requires detailed evaluation.

Purpose of the Study:

  • To assess the impact of low-dose subconjunctival mitomycin C (MMC) on fibroblast viability in rabbit ocular tissues.

Main Methods:

  • Subconjunctival injections of balanced salt solution (BSS), 0.025 mg MMC, or 0.005 mg MMC were administered to rabbits.
  • Conjunctival, scleral, and corneal tissue samples were collected 1 hour post-injection.
  • Fibroblast outgrowth was measured in cultured tissue samples.

Main Results:

  • MMC-treated groups showed significantly reduced scleral and conjunctival fibroblast outgrowth compared to the BSS control group.
  • Subconjunctival MMC demonstrated an inhibitory effect on conjunctival fibroblasts at 0 degrees and scleral fibroblast populations.

Conclusions:

  • Low-dose subconjunctival mitomycin C (MMC) exhibits significant fibroblast inhibitory effects on conjunctiva and sclera.
  • These findings are important for understanding the local tissue effects of MMC in ophthalmology.